Three options. Only one actually works for your business.
Schedule 4 medications cannot be marketed like skincare. Most clinics still try.
Cosmetic injectables is the most heavily regulated cosmetic category in Australia, by a long way. Anti-wrinkle injections and dermal fillers are Schedule 4 medications, which means the TGA Therapeutic Goods Advertising Code prohibits naming the brand (Botox, Dysport, Xeomin, Restylane, Juvederm, Stylage) in any public-facing advertising, prohibits patient testimonials, prohibits before-and-after photography in paid advertising, and restricts comparative effectiveness claims. On top of that the AHPRA Cosmetic Surgery Reforms (Sept 2023, ongoing tightening through 2024 and 2025) added a 12-month-rolling-consult requirement, a seven-day cooling-off period for certain procedures, and stricter informed-consent documentation. Most clinics in this vertical are quietly breaching one of the above and don't know until a complaint lands. The marketing job is to fill the nurse-injector diary inside these constraints, not despite them.
Good cosmetic-injectables marketing has three jobs that all have to run inside the compliance envelope. First, a drug-name-free service architecture: anti-wrinkle injections, dermal fillers, lip enhancement, masseter reduction, neuromodulator treatment, hyaluronic acid filler. The brand names never appear in public-facing copy, only in the in-clinic consent forms where they belong. Second, a clinician-credential-first positioning model: registered nurse-injector qualifications, cosmetic physician oversight, AACDS or ACAM membership, RACGP or ANZSCS credentials where applicable. The trust signal is the qualification, not the drug. Third, a fully automated 12-month rolling consult workflow that meets the AHPRA Cosmetic Surgery Reforms requirement without a spreadsheet falling over when a nurse is on leave.
Six agents, working in your accounts.
Account Lead, Web, SEO, Advertising, Social Media, and Content. One platform, one bill, you approve the work.
Sets the plan around two numbers that move the clinic: nurse-injector calendar utilisation and 12-month rolling consult completion rate (the AHPRA reform compliance metric, which most clinics still track on a spreadsheet). Briefs the other agents so every page, ad and post stays inside the TGA Therapeutic Goods Advertising Code and the AHPRA Cosmetic Surgery Reforms without sounding like a legal disclaimer.
Imports your existing site and ships a drug-name-free service architecture: anti-wrinkle injections, dermal fillers, lip enhancement, masseter reduction, all named generically. No Schedule 4 brand names anywhere on the public site. Plus treatment-plus-suburb pages, the informed-consent process walkthrough, and the 12-month rolling consult explainer. Brand names only appear on in-clinic consent forms where they belong.
Owns whether you appear in the map pack for 'cosmetic injectables near me', 'anti-wrinkle [suburb]' and 'lip filler [suburb]' (all drug-name-free). Complete Google Business Profile, MedicalBusiness schema, review prompts that don't solicit testimonials (because testimonials are restricted), technical fixes that keep you indexed.
Runs Meta ads on the clinician-credential angle (nurse-injector, cosmetic physician oversight, AACDS membership), with claims-checker pre-flight on every creative against TGA s42DLB. No Schedule 4 brand names, no testimonials, no before-and-after imagery, no patient endorsements in paid social. Google Ads on the drug-name-free high-intent searches your service pages already target.
Turns every in-clinic moment into educational, AHPRA-aligned content in your voice: the consult-room walkthrough, the informed-consent explainer, the 12-month-rolling-consult rationale, the nurse-injector credential post. Builds authority through education, not influencer endorsements. Upload one credential-wall or consult-room frame, the agent writes the caption with TGA and AHPRA checks baked in, you sign off between treatments.
Drafts the longer-form pieces serious clients search for between consults: 'what the AHPRA Cosmetic Surgery Reforms changed for clients', 'registered nurse-injector vs cosmetic physician, who should treat me', 'what informed consent actually covers in a cosmetic-injectables clinic'. Two a month, in your voice, that build defensible authority and double as the pre-qualification filter for serious clients.
Your first 30 days.
- Site audited and every Schedule 4 brand name removed from public-facing copy and metadata
- Anti-wrinkle, dermal filler, lip enhancement and masseter pages indexed with drug-name-free terminology
- 12-month rolling consult automation wired into your booking system to meet the AHPRA reform requirement
- Meta ad library cleansed of testimonials and before-and-after creative, refreshed with credential-led copy
- Informed-consent and seven-day cooling-off explainer pages live and linked from every service page
- Google Business Profile reset with drug-name-free service list and clinician-credential surface
- 'What the AHPRA Cosmetic Surgery Reforms changed for clients' blog drafted and linked from the consult page
- Nurse-injector calendar utilisation and rolling-consult-completion targets delivered by Sam
Cosmetic injectables is the most heavily regulated cosmetic category in Australia and the regulation is tightening every year. The 2023 AHPRA Cosmetic Surgery Reforms changed the consult model, the 2024 and 2025 TGA enforcement on Schedule 4 brand-name advertising changed the ad model, and the testimonial and before-and-after restrictions changed the content model. Most clinics in this vertical are quietly breaching at least one of these and only find out when a notification arrives. The clinics that thrive build authority through clinician credentials and educational content, run drug-name-free ads, and automate the 12-month rolling consult so the compliance workflow doesn't fall over when a nurse takes a week off.
Agencies are too dear to actually do this work for $4.5k a month and most don't know what s42DLB is. Tools are cheap but the AHPRA-aligned consult workflow you mean to set up after the next compliance scare is still on a spreadsheet. In-House is the third option: for $299 a month the agents ship drug-name-free service pages, run claims-checked Meta ads, post educational social, and automate the rolling consult. You upload one treatment-room photo, approve the week, done.